Mass General Brigham and Tampa General Hospital have bolstered their partnership with the addition of new programs and services, the organizations announced Tuesday.
Several services have been added in Florida, including a chimeric antigen receptor T-cell therapy, a type of cancer treatment that uses a patient's own immune system to fight the disease, and a bone marrow transplant program. The partnership, which began in 2021, has also expanded healthcare services for veterans and service members in Florida.
Related: Tampa General boosts USF Health investment, plots big expansion
Boston-based Mass General Brigham and Tampa General Hospital did not immediately respond to a request for comment on investment costs and future plans for the partnership.
Tampa General has been working on its own growth initiatives. Last month, the system said it planned to invest more than $162 million in University of South Florida Health to further its expansion statewide.
Mass General Brigham has also set its sights on growth, including at-home care and the use of artificial intelligence.
In March, the system partnered with GE HealthCare to boost research into AI applications. It's also using AI in research related to social determinants of health.
